Difficulty: Medium
Average Score: 78%
Practice
Which one of the following statements about 'one daily' dosing with aminoglycosides is false?
Correct answer
B
Rationale
In the context of drugs for the immune system, aminoglycosides are antibiotics primarily used for treating severe bacterial infections. When considering 'one daily' dosing with aminoglycosides, it is crucial to understand the pharmacokinetics and pharmacodynamics of these drugs.
Option A states that 'one daily' dosing is convenient for outpatient therapy. This statement is true because administering the medication once a day simplifies the dosing regimen for patients who are not in a hospital setting.
Option B, which is the correct answer, states that adjustment of dosage is less important in renal insufficiency. This statement is false because aminoglycosides are known to be nephrotoxic, meaning they can cause kidney damage. In patients with renal insufficiency, dosage adjustments are critical to prevent further harm to the kidneys.
Option C suggests that less nursing time is required with 'one daily' dosing. While it may seem that administering a medication once a day requires less nursing time, this is not a significant factor in the choice of dosing regimen for aminoglycosides.
Option D states that 'one daily' dosing is often less toxic than conventional (multiple) dosing regimens. This statement is generally false as aminoglycosides are known for their potential toxicity, regardless of the dosing frequency. Monitoring for toxicity is essential regardless of the dosing regimen chosen.
In an educational context, understanding the dosing regimens and considerations for aminoglycosides is crucial for healthcare providers to ensure safe and effective treatment for patients. Knowledge of the pharmacological properties, dosing adjustments, and monitoring requirements is essential in clinical practice to optimize patient outcomes and minimize adverse effects.
Option A states that 'one daily' dosing is convenient for outpatient therapy. This statement is true because administering the medication once a day simplifies the dosing regimen for patients who are not in a hospital setting.
Option B, which is the correct answer, states that adjustment of dosage is less important in renal insufficiency. This statement is false because aminoglycosides are known to be nephrotoxic, meaning they can cause kidney damage. In patients with renal insufficiency, dosage adjustments are critical to prevent further harm to the kidneys.
Option C suggests that less nursing time is required with 'one daily' dosing. While it may seem that administering a medication once a day requires less nursing time, this is not a significant factor in the choice of dosing regimen for aminoglycosides.
Option D states that 'one daily' dosing is often less toxic than conventional (multiple) dosing regimens. This statement is generally false as aminoglycosides are known for their potential toxicity, regardless of the dosing frequency. Monitoring for toxicity is essential regardless of the dosing regimen chosen.
In an educational context, understanding the dosing regimens and considerations for aminoglycosides is crucial for healthcare providers to ensure safe and effective treatment for patients. Knowledge of the pharmacological properties, dosing adjustments, and monitoring requirements is essential in clinical practice to optimize patient outcomes and minimize adverse effects.